These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11447076)

  • 41. Evaluation of platelet reactivity during combined antiplatelet therapy in patients with stable coronary artery disease in relation to diabetes type 2 and the GPIIB/IIIA receptor gene polymorphism.
    Jastrzebska M; Lisman D; Szelepajlo A; Oledzki S; Chelstowski K; Clark JS; Siennicka A
    J Physiol Pharmacol; 2019 Apr; 70(2):. PubMed ID: 31356179
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased binding of fibrinogen to glycoprotein IIIa-proline33 (HPA-1b, PlA2, Zwb) positive platelets in patients with cardiovascular disease.
    Goodall AH; Curzen N; Panesar M; Hurd C; Knight CJ; Ouwehand WH; Fox KM
    Eur Heart J; 1999 May; 20(10):742-7. PubMed ID: 10329065
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glycoprotein IIIa Pl(A) polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly.
    Mikkelsson J; Perola M; Laippala P; Savolainen V; Pajarinen J; Lalu K; Penttilä A; Karhunen PJ
    Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2573-8. PubMed ID: 10521390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of platelet glycoprotein IIb-IIIa number and glycoprotein IIIa Leu33Pro polymorphism on platelet aggregation and sensitivity to glycoprotein IIb-IIIa antagonists.
    Sirotkina OV; Khaspekova SG; Zabotina AM; Shimanova YV; Mazurov AV
    Platelets; 2007 Nov; 18(7):506-14. PubMed ID: 17957566
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation.
    De Marco L; Girolami A; Zimmerman TS; Ruggeri ZM
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7424-8. PubMed ID: 2932740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation.
    De Marco L; Girolami A; Russell S; Ruggeri ZM
    J Clin Invest; 1985 Apr; 75(4):1198-203. PubMed ID: 3157702
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Platelet glycoprotein IIIa PlA1/A2 polymorphism and its relationship with diabetic nephropathy in type 2 diabetic patients.
    Scaglione L; Gambino R; Lillaz E; Bo S; Cassader M; Pagano G; Cavallo-Perin P
    Clin Nephrol; 2000 Apr; 53(4):253-6. PubMed ID: 10809411
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease.
    Anderson JL; King GJ; Bair TL; Elmer SP; Muhlestein JB; Habashi J; Carlquist JF
    J Am Coll Cardiol; 1999 Mar; 33(3):727-33. PubMed ID: 10080474
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The platelet Pl(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction.
    Bray PF; Cannon CP; Goldschmidt-Clermont P; Moyé LA; Pfeffer MA; Sacks FM; Braunwald E
    Am J Cardiol; 2001 Aug; 88(4):347-52. PubMed ID: 11545752
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estradiol increases platelet aggregation in Pl(A1/A1) individuals.
    Boudoulas KD; Montague CR; Goldschmidt-Clermont PJ; Cooke GE
    Am Heart J; 2006 Jul; 152(1):136-9. PubMed ID: 16824843
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of glycoprotein IIIa PlA2 polymorphism on outcome of patients with stable coronary artery disease and effect of smoking.
    Lopes NH; Pereira AC; Hueb W; Soares PR; Lanz JR; Gersh BJ; de Oliveira S; Cesar LA; Ramires JF; Krieger JE
    Am J Cardiol; 2004 Jun; 93(12):1469-72. PubMed ID: 15194015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low incidence of paradoxical platelet activation by glycoprotein IIb/IIIa inhibitors.
    Weber AA; Meila D; Jacobs C; Weber S; Kelm M; Strauer BE; Zotz RB; Scharf RE; Schrör K
    Thromb Res; 2002 Apr; 106(1):25-9. PubMed ID: 12165285
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A radical explanation for the effect of the HPA-1b polymorphism in platelet alphaIIbbeta3-integrin?
    Goodall AH
    Thromb Haemost; 2008 Nov; 100(5):731-2. PubMed ID: 18989509
    [No Abstract]   [Full Text] [Related]  

  • 54. The effect of physiological levels of fibrinogen on platelet aggregation.
    Meade TW; Vickers MV; Thompson SG; Seghatchian MJ
    Thromb Res; 1985 Jun; 38(5):527-34. PubMed ID: 4012675
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased platelet-monocyte aggregation in male claudicants with the Pl(A1/A2) polymorphism of Gp IIb/IIIa.
    McCaslin J; Ashour H; Bhattacharya V; Cleanthis M; Daly A; Stansby G
    Eur J Vasc Endovasc Surg; 2008 Aug; 36(2):132-137. PubMed ID: 18396070
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Platelet glycoprotein IIIa pl(a) polymorphism and effects of aspirin on thrombin generation.
    Szczeklik A; Sanak M; Undas A
    Circulation; 2001 Feb; 103(6):E33-4. PubMed ID: 11171808
    [No Abstract]   [Full Text] [Related]  

  • 57. PIA1/A2 polymorphism of the platelet glycoprotein receptor IIb/IIIIa and its correlation to cerebrovascular diseases: an appraisal.
    Wiwanitkit V
    Clin Appl Thromb Hemost; 2009; 15(4):458-60. PubMed ID: 18160561
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interaction between a genetic variant of the platelet fibrinogen receptor and fibrinogen levels in determining the risk of cardiovascular events.
    Boekholdt SM; Peters RJ; de Maat MP; Zwinderman AH; van Der Wall EE; Reitsma PH; Jukema JW; Kastelein JJ
    Am Heart J; 2004 Jan; 147(1):181-6. PubMed ID: 14691438
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
    Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective induction of a glycoprotein IIIa ligand-induced binding site by fibrinogen and von Willebrand factor.
    Mondoro TH; Wall CD; White MM; Jennings LK
    Blood; 1996 Nov; 88(10):3824-30. PubMed ID: 8916946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.